Rompe Pecho

Product NDC: 58593-265
11-digit product format: 585930265
Labeler code: 58593
Product ID: 58593-265_411e96f1-d9a3-1820-e063-6294a90a8a69
Type: HUMAN OTC DRUG
Nonproprietary name: Guaifenesin
Dosage form: LIQUID
Route: ORAL
Labeler: Efficient Laboratories, Inc.
Application: M012
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1999-03-01
Substance: GUAIFENESIN
Active strength: 100 mg/5mL
Pharmacologic classes: Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	58593-265	58593-265-04	D	Discontinued by firm		2026-10-23

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Rompe Pecho
Brand name suffix: SF
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GUAIFENESIN	100 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
495W7451VQ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310604	Internal RxNorm lookup
1112205	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
31ff48fc-9603-413c-ab7c-2598b3e08f9c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
4fe95224-f543-4dbb-9445-8cca122b48c8	Product name	1	20150609
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
106ff02a-57e1-4c4c-a307-fd582ff4e311	Product name	1	20150212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
58593-265-04	2023-08-03	Drug Facts
58593-265-04	2023-08-03	Drug Facts
58593-265-06	2023-08-03	Drug Facts
58593-265-06	2023-08-03	Drug Facts
58593-265-04	2023-07-28	Drug Facts
58593-265-04	2023-07-28	Drug Facts
58593-265-06	2023-07-28	Drug Facts
58593-265-06	2023-07-28	Drug Facts
58593-265-04	2020-02-16	Drug Facts
58593-265-04	2020-02-16	Drug Facts
58593-265-06	2020-02-16	Drug Facts
58593-265-06	2020-02-16	Drug Facts
58593-265-04	2020-01-31	Drug Facts
58593-265-04	2020-01-31	Drug Facts
58593-265-06	2020-01-31	Drug Facts
58593-265-06	2020-01-31	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
58593-265-04	Rompe PechoSF	118 mL in 1 BOTTLE	LIQUID	118		15
58593-265-06	Rompe PechoSF	178 mL in 1 BOTTLE	LIQUID	178		15

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
CAULOPHYLLUM THALICTROIDES ROOT	INACTIVE INGREDIENT	JTJ6HH6YEH	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
ECHINACEA, UNSPECIFIED	INACTIVE INGREDIENT	4N9P6CC1DX	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
EUCALYPTUS OIL	INACTIVE INGREDIENT	2R04ONI662	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
GINKGO	INACTIVE INGREDIENT	19FUJ2C58T	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
GLYCYRRHIZA GLABRA	INACTIVE INGREDIENT	2788Z9758H	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
GOLDENSEAL	INACTIVE INGREDIENT	ZW3Z11D0JV	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
HOREHOUND	INACTIVE INGREDIENT	K08036XEJV	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
MYRRH	INACTIVE INGREDIENT	JC71GJ1F3L	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
POTASSIUM CITRATE	INACTIVE INGREDIENT	EE90ONI6FF	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
PRUNUS SEROTINA BARK	INACTIVE INGREDIENT	5D48E975HA	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
ULMUS RUBRA BARK	INACTIVE INGREDIENT	91QY4PXU8Q	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
VERBASCUM DENSIFLORUM LEAF	INACTIVE INGREDIENT	9936O846LI	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4
ZINC SULFATE	INACTIVE INGREDIENT	89DS0H96TB	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58593-265	ROMPE PECHO SF (GUAIFENESIN) LIQUID [EFFICIENT LABORATORIES, INC.]	14	Current NDC, Legacy NDC, 2 package rows	20241016_31ff48fc-9603-413c-ab7c-2598b3e08f9c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 159 of 178 · 3,551 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Topcare childrens allergy	DIPHENHYDRAMINE HYDROCHLORIDE	Topco Associates LLC	6b784cde-3152-4421-a825-dd1fc601aa7a	2024-07-17	Warnings	Exact identifier application number: M012
Mucus Relief Severe Congestion and Cough Maximum Strength	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	Walgreens	4c6b6379-3a7f-4507-a792-7b69a7f3ba82	2024-07-17	Warnings	Exact identifier application number: M012
Mucus Relief Cold Flu Sore Throat Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL	Walgreens	04defcf6-e20e-402b-b725-d9394a0146b1	2024-07-16	Warnings	Exact identifier application number: M012
basic care allergy relief	DIPHENHYDRAMINE HYDROCHLORIDE	Amazon.com Services LLC	7d237d37-21c7-476d-a8b7-d91ea1b472ee	2024-07-16	Warnings	Exact identifier application number: M012
Berkley and Jensen Allergy Relief	DIPHENHYDRAMINE HYDROCHLORIDE	BJWC	b52fc311-8853-4116-941b-8be35456abba	2024-07-16	Warnings	Exact identifier application number: M012
Mucus Relief All In One Daytime Nighttime Cold Flu Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACETAMINOPHEN, DIPHENHYDRAMINE HCL PHENYLEPHRINE HCL	Walgreens	0b9a4438-7d13-484c-a614-2dedc24974dc	2024-07-16	Warnings	Exact identifier application number: M012
allergy	DIPHENHYDRAMINE HYDROCHLORIDE	Publix Super Markets Inc	23a98385-28cc-4fac-8c87-b3ced8106532	2024-07-16	Warnings	Exact identifier application number: M012
Walgreens Moisturizing Ultra Fine Mist with Aloe	0.05% OXYMETAZOLINE	Walgreens Company	aad01028-cbe0-4c10-adbc-d157bfa5af09	2024-07-16	Warnings	Exact identifier application number: M012
Basic Care severe cold and cough	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE	Amazon.com Services LLC	924bf427-b054-46af-b341-ff162946cd58	2024-07-15	Warnings	Exact identifier application number: M012
Maximum Strength Cold Tabs	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE	JHK DBA American Safety & First Aid	e7d4fe9a-eb09-4266-90c9-290f61ce6ad0	2024-07-15	Warnings	Exact identifier application number: M012
ACTIDOM DA	CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE	ACTIPHARMA, LLC	7797c22e-ffeb-4798-9fb6-aa64cf077ba7	2024-07-15	Warnings	Exact identifier application number: M012
Nighttime severe cold and flu	ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	TARGET CORPORATION	1cf3064d-4ddd-63b9-e063-6294a90aa547	2024-07-11	Warnings	Exact identifier application number: M012
Daytime Cold and Flu	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCL	TARGET CORPORATION	1ccbdb53-3f70-28da-e063-6394a90a9ae0	2024-07-09	Warnings	Exact identifier application number: M012
AXIV Allergy Relief	DIPHENHYDRAMINE HYDROCHLORIDE	VIVUNT PHARMA LLC	1cd2a6f1-31ad-e507-e063-6394a90aba58	2024-07-09	Warnings	Exact identifier application number: M012
Poly Hist Forte	DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE	Poly Pharmaceuticals, Inc.	8aa0015b-8fc1-7951-e053-2a95a90a8e72	2024-07-09	Warnings	Exact identifier application number: M012
DECONEX DMX	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	Poly Pharmaceuticals, Inc.	8aab8e5c-1633-2e5a-e053-2a95a90adcc5	2024-07-09	Warnings	Exact identifier application number: M012
Deconex IR	GUAIFENESIN AND PHENYLEPHRINE HCL	Poly Pharmaceuticals, Inc.	4710095e-3dae-4a39-8a98-873012e1f003	2024-07-09	Warnings	Exact identifier application number: M012
Diabetic Tussin Sore Throat and Cough Cherry	BENZOCAINE AND DEXTROMETHORPHAN HBR	MEDTECH PRODUCTS INC	e9327079-e0fc-4c95-b1d5-bc1b74870c9b	2024-07-09	Warnings	Exact identifier application number: M012
nasal	OXYMETAZOLINE HYDROCHLORIDE	Rite Aid Corporation	fac859a4-e23a-4879-af6c-26368455506d	2024-07-05	Warnings	Exact identifier application number: M012
Severe Throat Drops	MENTHOL ICE	Target Corporation Inc.	1876b221-fa60-5269-e063-6394a90a6963	2024-07-04	Warnings	Exact identifier application number: M012

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310604	guaiFENesin 100 MG in 5 mL Oral Solution	PSN	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
1112205	Rompe Pecho 100 MG in 5 mL Oral Solution	PSN	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
1112205	guaifenesin 20 MG/ML Oral Solution [Rompe Pecho]	SBD	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
310604	guaifenesin 20 MG/ML Oral Solution	SCD	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
310604	guaifenesin 100 MG per 5 ML Oral Solution	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
310604	guaifenesin 100 MG per 5 ML Oral Syrup	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
310604	guaifenesin 200 MG per 10 ML Oral Solution	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
310604	guaifenesin 300 MG per 15 ML Oral Solution	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
310604	guaifenesin 400 MG per 20 ML Oral Solution	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
1112205	Rompe Pecho 100 MG per 5 ML Oral Solution	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15
1112205	Rompe Pecho 20 MG/ML Oral Solution	SY	31ff48fc-9603-413c-ab7c-2598b3e08f9c	15

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
58593-265-04	58593026504	118 mL in 1 BOTTLE (58593-265-04)	118 ml	2015-01-01	0000-00-00	No	No	Current
58593-265-06	58593026506	178 mL in 1 BOTTLE (58593-265-06)	178 ml	1999-03-01	0000-00-00	No	No	Current